Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets
Prepaid expenses	$ 1,022	$ 1,022
Total current assets	1,022	1,022
Office and laboratory equipment and leasehold improvements	0	0
Automobile & trucks	26,400	26,400
Less: Accumulated depreciation	(21,120)	(15,840)
Total property and equipment, net	5,280	10,560
Other assets - deposit	0	0
TOTAL ASSETS	6,302	11,582
Current liabilities
Accounts payable	81,070	81,070
Accrued expenses	7,286,651	6,798,920
Notes payable	25,800	25,800
Convertible notes payable, net of discount	64,500	54,500
Loan from shareholder	720,969	731,796
Total liabilities	8,178,990	7,692,087
Commitments and Contingencies	0	0
Stockholders' deficit:
Common stock, par value $0.001 per share, 300,000,000 shares authorized; 34,083,319 and 24,071,255 shares issued and outstanding, respectively	34,083	24,071
Common stock to be issued	53,572	53,572
Additional paid-in capital	23,985,064	23,475,776
Accumulated deficit	(32,271,446)	(31,259,962)
Total stockholders' deficit of GeneThera, Inc.	(8,172,688)	(7,680,504)
TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT	6,302	11,582
Preferred Stock Value	0
Series A Preferred Stock [Member]
Stockholders' deficit:
Preferred Stock Value		0
Series B Preferred Stock [Member]
Stockholders' deficit:
Preferred Stock Value	$ 26,039	$ 26,039